Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia models

Journal:
Cell Stem Cell
Published:
Affiliations:
4
Authors:
21
Institutions Authors Share
Institute of Zoology (IOZ), CAS, China
8.333333
0.40
Institute for Stem Cell and Regeneration, CAS, China
8.333333
0.40
University of Chinese Academy of Sciences (UCAS), China
3.833333
0.18
Northeast Agricultural University (NEAU), China
0.500000
0.02